Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Humanitarian Diplomacy, a Fig Leaf for Extrem Violence
09/28/2016. Interview with Michaël Neuman and Fabrice Weissman, research directors at Crash.
UN relief wing appeals for record $22.5 billion in aid for 2018
12/01/2017. 136 million people face urgent needs because of protracted conflicts, natural disasters, epidemics and displacement.
The Future of Humanitarian Response 2017
02/14/2017. In 2015, the World Economic Forum began working with leaders from across sectors to develop a coherent conversation around humanitarian issues.
